Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 77
Filtrar
1.
PLoS One ; 19(2): e0297590, 2024.
Artigo em Inglês | MEDLINE | ID: mdl-38335202

RESUMO

Although mucormycosis is an important cause of morbidity and mortality in children with cancer, our understanding of the typical characteristics of these infections is incomplete. We reviewed all cases of mucormycosis diagnosed at a single pediatric cancer center over 5 decades to identify the clinical features of mucormycosis in pediatric oncology patients and to identify risk factors for mortality. There were 44 cases of mucormycosis diagnosed between 1970-2019. Most patients (89%) had hematological malignancies and a history of prolonged and severe neutropenia (91%). In this series, hyperglycemia and exposure to corticosteroids were common. Pulmonary (36%) and disseminated infections (32%) were most common; rhino-orbital-cerebral infections were relatively infrequent (11%). Rhizopus spp. was the most common etiological agent (40%) followed by Mucor spp. (31%), and Cunninghamella spp. (19%). Overall mortality was 44% and 51% and attributable mortality was 39% and 41% at the end of antifungal therapy and end of follow up, respectively. Attributable mortality fell to 18% in 2010-2019, from 58-60% in previous decades; adjunctive surgery was associated with decreased mortality. Mortality remains unacceptably high despite aggressive antifungal therapy and adjunctive surgery, suggesting novel therapeutic strategies are needed.


Assuntos
Neoplasias Hematológicas , Transplante de Células-Tronco Hematopoéticas , Mucormicose , Neutropenia , Humanos , Criança , Mucormicose/diagnóstico , Antifúngicos/uso terapêutico , Transplante de Células-Tronco Hematopoéticas/efeitos adversos , Estudos de Coortes , Neoplasias Hematológicas/complicações , Neoplasias Hematológicas/tratamento farmacológico , Neutropenia/complicações
2.
Arch. cardiol. Méx ; 93(3): 267-275, jul.-sep. 2023. tab, graf
Artigo em Espanhol | LILACS-Express | LILACS | ID: biblio-1513579

RESUMO

Resumen Introducción: La confiabilidad de la presión sistólica arterial pulmonar por ecocardiografía transtorácica se encuentra limitada por su variabilidad para definir la hipertensión pulmonar. Objetivo: Conocer la variabilidad en la presión sistólica arterial pulmonar estimada por ecocardiografía en la hipertensión pulmonar. Métodos: En el periodo 2016-2020 se captaron sujetos con hipertensión pulmonar que tuvieron estimada la presión sistólica de la arteria pulmonar por ecocardiografía transtorácica y por cateterismo cardiaco derecho. Se obtuvieron sus variables demográficas. Los datos se analizaron con el estadístico descriptivo de Bland-Altman y el coeficiente de correlación intraclase (intervalo de confianza al 95%). Resultados: Se estudiaron 152 sujetos, edad 60 ± 12 años. Índice de masa corporal 27.64 ± 4.69 kg/m2. La presión sistólica de la arteria pulmonar por ecocardiografía transtorácica 58.99 ± 18.62 vs. cateterismo cardiaco 55.43 ± 16.79. Diferencia media (sesgo) -3.6 (29.1, -36.2) y coeficiente de correlación intraclase 0.717 (0.610, 0.794). Conclusiones: La variabilidad es amplia y el acuerdo es sustancial con la presión sistólica de la arteria pulmonar. Se aconseja estimarla solo como tamizaje de la hipertensión pulmonar.


Abstract Introduction: The reliability of pulmonary arterial systolic pressure by transthoracic echocardiography is limited by its variability to define pulmonary hypertension. Objective: To know the variability of pulmonary arterial systolic pressure estimated by echocardiography in pulmonary hypertension. Their demographic variables were obtained. Methods: From 2016-2020 subjects with pulmonary hypertension were recruited, with pulmonary artery systolic pressure estimated by transthoracic echocardiography and by right heart catheterization. Data were analyzed using the Bland-Altman descriptive statistic and the intraclass correlation coefficient (95% confidence interval). Results: 152 subjects, age 60 ± 12 years, were studied. Body mass index 27.64 ± 4.69 kg/m2. The pulmonary artery systolic pressure estimated by transthoracic echocardiography 58.99 ± 18.62 vs. cardiac catheterization 55.43 ± 16.79 mmHg. Mean difference (bias) -3.6 (29.1, -36.2) and intraclass correlation coefficient 0.717 (0.610, 0.794). Conclusions: Variability is wide, and agreement is substantial for pulmonary artery systolic pressure. It is recommended to estimate only as screening for pulmonary hypertension.

3.
Mar Drugs ; 19(11)2021 Oct 30.
Artigo em Inglês | MEDLINE | ID: mdl-34822487

RESUMO

Green extraction was applied to Argentinean shortfin squid (Illex argentinus) viscera, consisting of a wet pressing method including a drying step, mechanic pressing, centrifugation of the resulting slurry, and oil collection. To maximise the oil yield and ω3 fatty acid content and to minimise the oil damage degree, a response surface methodology (RSM) design was developed focused on the drying temperature (45-85 °C) and time (30-90 min). In general, an increase of the drying time and temperature provided an increase in the lipid yield recovery from the viscera. The strongest drying conditions showed a higher recovery than 50% when compared with the traditional chemical method. The docosahexaenoic and eicosapentaenoic acid contents in the extracted oil revealed scarce dependence on drying conditions, showing valuable ranges (149.2-166.5 and 88.7-102.4 g·kg-1 oil, respectively). Furthermore, the values of free fatty acids, peroxides, conjugated dienes, and ω3/ω6 ratio did not show extensive differences by comparing oils obtained from the different drying conditions. Contrary, a polyene index (PI) decrease was detected with increasing drying time and temperature. The RSM analysis indicated that optimised drying time (41.3 min) and temperature (85 °C) conditions would lead to 74.73 g·kg-1 (oil yield), 1.87 (PI), and 6.72 (peroxide value) scores, with a 0.67 desirability value.


Assuntos
Decapodiformes , Ácidos Graxos Ômega-3/química , Animais , Organismos Aquáticos , Química Verde , Vísceras/química
4.
Clin Lymphoma Myeloma Leuk ; 21(12): e985-e999, 2021 12.
Artigo em Inglês | MEDLINE | ID: mdl-34511320

RESUMO

BACKGROUND: Ibrutinib demonstrated remarkable efficacy and favorable tolerability in patients with untreated or relapsed/refractory (R/R) chronic lymphocytic leukemia (CLL), including those with high-risk genetic alterations. The IBRORS-CLL study assessed the characteristics, clinical management and outcome of CLL patients receiving ibrutinib in routine clinical practice in Spain. PATIENTS: Observational, retrospective, multicenter study in CLL patients who started single-agent ibrutinib as first-line treatment or at first or second relapse between January 2016 and January 2019. RESULTS: A total of 269 patients were included (median age: 70.9 years; cardiovascular comorbidity: 55.4%, including hypertension [47.6%] and atrial fibrillation [AF] [7.1%]). Overall, 96.7% and 69% of patients underwent molecular testing for del(17p)/TP53 mutation and IGHV mutation status. High-risk genetic features included unmutated IGHV (79%) and del(17p)/TP53 mutation (first-line: 66.3%; second-line: 23.1%). Overall, 84 (31.2%) patients received ibrutinib as first-line treatment, and it was used as second- and third-line therapy in 121 (45.0%) and 64 (23.8%) patients. The median progression-free survival and overall survival were not reached irrespective of del(17p)/TP53, or unmutated IGHV. Common grade ≥3 adverse events were infections (12.2%) and bleeding (3%). Grade ≥3 AF occurred in 1.5% of patients. CONCLUSION: This real-world study shows that single-agent ibrutinib is an effective therapy for CLL, regardless of age and high-risk molecular features, consistent with clinical trials. Additionally, single-agent ibrutinib was well tolerated, with a low rate of cardiovascular events. This study also emphasized a high molecular testing rate of del(17p)/TP53 mutation and IGHV mutation status in clinical practice according to guideline recommendations.


Assuntos
Leucemia Linfocítica Crônica de Células B , Adenina/análogos & derivados , Idoso , Humanos , Piperidinas , Pirazóis/efeitos adversos , Pirimidinas/efeitos adversos , Estudos Retrospectivos , Espanha/epidemiologia
5.
Rev. invest. clín ; 73(4): 222-230, Jul.-Aug. 2021. tab, graf
Artigo em Inglês | LILACS | ID: biblio-1347568

RESUMO

Background: Information regarding diagnosis, treatment, and follow-up of patients with type 1 diabetes (PWT1D) in Mexico is limited. We developed an on-line platform Registro Nacional de Pacientes con Diabetes Tipo 1 (RENACED-DT1). Objective: The objective of the study was to describe the characteristics and healthcare of PWT1D registered in RENACED-DT1. Methods: Analyses of 965 PWT1D from July 2014 to January 2018 in different endocrinology clinics around Mexico. Results: Sixty-one percent were female with median age of 21 years, age at diagnosis 11 years, and disease duration at inclusion 8.2 years. Treatment regimen was basal-bolus in 61% and insulin-pumps in 21% (mainly in the private sector); 33.3% with self-monitoring of blood-glucose (SMBG) ≥4 times/day. Mean HbA1c at last follow-up was 8.7 ± 2.1% (72±23 mmol/mol), 18% had HbA1c < 7% (53 mmol/mol), and 35% > 9% (75 mmol/mol). SMBG ≥ 4 times/day was associated with HbA1c < 7%. Time since diagnosis > 10 years, female sex, BMI ≥ 30 kg/m2, SMBG < 4 times/day, and any hypoglycemia were associated with microvascular complications (p < 0.05). Conclusions: Percentage of patients achieving HbA1c < 7% is low; increased blood glucose monitoring is associated with better glycemic control. The achievement of optimal glycemic control must be increased to reduce the incidence of chronic complications and improve quality of life in PWT1D.


Assuntos
Humanos , Masculino , Feminino , Criança , Adolescente , Adulto Jovem , Diabetes Mellitus Tipo 1/terapia , Diabetes Mellitus Tipo 1/epidemiologia , Qualidade de Vida , Glicemia , Hemoglobinas Glicadas/análise , Automonitorização da Glicemia , Sistema de Registros , Hipoglicemiantes , Insulina , México/epidemiologia
6.
Molecules ; 26(11)2021 May 22.
Artigo em Inglês | MEDLINE | ID: mdl-34067234

RESUMO

There is consistent evidence that long-chain polyunsaturated fatty acids (LCPUFA) belonging to the n-3 series, i.e., eicosapentaenoic (20:5n-3, EPA) and docosahexaenoic (22:6n-3, DHA) acids, decrease the risk of heart, circulatory and inflammatory diseases. Furthermore, the bioavailability of such fatty acids has been shown to depend on their location in triacylglycerol (TG) molecules at the sn-2 position. Consequently, great attention has been accorded to the synthesis of structured acylglycerols (sAG), which include EPA or DHA at the sn-2 position. The aim of this work was to synthesize sAG starting from deodorized refined commercial salmon oil. For this, immobilized lipase B from Candida antarctica (nonspecific) was used as a catalyst for the intra-interesterification process under CO2 supercritical conditions (CO2SC). According to the CO2SC reaction time, three different fractions including sAG compounds were obtained. The location of EPA and DHA at the sn-2 position in the resulting glycerol backbone was identified by mass spectrometry (MALDI-TOF) analysis. In all fractions obtained, a marked decrease in the starting TG content was observed, while an increase in the DHA content at the sn-2 position was detected. The fraction obtained after the longest reaction time period (2 h) led to the highest yield of sn-2 position DHA in the resulting sAG molecule.


Assuntos
Ácidos Docosa-Hexaenoicos/química , Ácido Eicosapentaenoico/química , Óleos de Peixe/química , Glicerídeos/síntese química , Triglicerídeos/química , Animais , Basidiomycota , Catálise , Técnicas de Química Analítica , Chile , Cromatografia em Camada Fina , Esterificação , Ésteres/química , Ácidos Graxos/química , Humanos , Hidrólise , Lipase/química , Lipídeos/química , Espectrometria de Massas , Probabilidade , Reprodutibilidade dos Testes , Alimentos Marinhos/análise , Espectrometria de Massas por Ionização e Dessorção a Laser Assistida por Matriz
7.
Toxins (Basel) ; 13(2)2021 02 11.
Artigo em Inglês | MEDLINE | ID: mdl-33670398

RESUMO

Dried fig is susceptible to infection by Aspergillus flavus, the major producer of the carcinogenic mycotoxins. This fruit may be contaminated by the fungus throughout the entire chain production, especially during natural sun-drying, post-harvest, industrial processing, storage, and fruit retailing. Correct management of such critical stages is necessary to prevent mould growth and mycotoxin accumulation, with temperature being one of the main factors associated with these problems. The effect of different temperatures (5, 16, 25, 30, and 37 °C) related to dried-fig processing on growth, one of the regulatory genes of aflatoxin pathway (aflR) and mycotoxin production by A. flavus, was assessed. Firstly, growth and aflatoxin production of 11 A. flavus strains were checked before selecting two strains (M30 and M144) for in-depth studies. Findings showed that there were enormous differences in aflatoxin amounts and related-gene expression between the two selected strains. Based on the results, mild temperatures, and changes in temperature during drying and storage of dried figs should be avoided. Drying should be conducted at temperatures >30 °C and close to 37 °C, while industry processing, storage, and retailing of dried figs are advisable to perform at refrigeration temperatures (<10 °C) to avoid mycotoxin production.


Assuntos
Aflatoxinas/análise , Aspergillus flavus/metabolismo , Ficus/microbiologia , Microbiologia de Alimentos , Conservação de Alimentos , Armazenamento de Alimentos , Frutas/microbiologia , Temperatura , Aflatoxinas/genética , Aspergillus flavus/genética , Aspergillus flavus/crescimento & desenvolvimento , Proteínas de Ligação a DNA/genética , Proteínas de Ligação a DNA/metabolismo , Dessecação , Proteínas Fúngicas/genética , Proteínas Fúngicas/metabolismo , Regulação Fúngica da Expressão Gênica , Fatores de Tempo , Fatores de Transcrição/genética , Fatores de Transcrição/metabolismo
8.
Chest ; 160(3): 1006-1016, 2021 09.
Artigo em Inglês | MEDLINE | ID: mdl-33689782

RESUMO

BACKGROUND: Different lung ultrasound (LUS) scanning protocols have been used, and the results in terms of diagnostic accuracy are heterogeneous. RESEARCH QUESTIONS: What is the diagnostic accuracy of the LUS score to predict moderate to severe bronchopulmonary dysplasia (msBPD)? Does scanning of posterior lung fields improve the diagnostic accuracy? STUDY DESIGN AND METHODS: This was a multicenter prospective, observational study in six centers. Two LUS aeration scores, one involving only anterolateral lung fields and the other adding the posterior fields were obtained at birth, on the third day of life (DOL), on the seventh DOL, on the 14th DOL, and on the 21st DOL. The diagnostic accuracy of both scores to predict msBPD was assessed at each time point. RESULTS: Eight hundred thirty-two LUS examinations in 298 infants were included. Both LUS score using anterolateral and posterior fields and LUS score using only anterolateral fields showed a similar moderate diagnostic accuracy to predict msBPD on the third DOL (area under the receiver operating characteristic curve [AUC] 95% CI, 0.68-0.85 vs 0.68-0.85; P = .97), seventh DOL (AUC 95% CI, 0.74-0.85 vs 0.74-0.84; P = .26), and 21st DOL (AUC 95% CI, 0.72-0.86 vs 0.74-0.88; P = .17). The LUS score using anterolateral and posterior fields was slightly more accurate at 14th DOL (AUC 95% CI, 0.69-0.83 vs 0.66-0.80; P = .01). A cutoff of 8 points in the LUS score using only anterolateral fields on the seventh DOL provided a sensitivity, specificity, positive likelihood ratio, and negative likelihood ratio of 70%, 79%, 3.3, and 0.38, respectively, to predict msBPD. Adding gestational age (GA) and sex improved the discriminative value without significant differences compared with a predictive model based on multiple clinical variables: AUC 95% CI, 0.77-0.88 vs 0.80-0.91 (P = .52). INTERPRETATION: The LUS score is able to predict msBPD from the third DOL with a moderate diagnostic accuracy. Scanning posterior lung fields slightly improved diagnostic accuracy only at the 14th DOL. Adding GA and sex improves the diagnostic accuracy of the LUS scores. The LUS score is useful to stratify BPD risk early after birth.


Assuntos
Displasia Broncopulmonar/diagnóstico , Pulmão/diagnóstico por imagem , Ultrassonografia , Confiabilidade dos Dados , Feminino , Idade Gestacional , Humanos , Recém-Nascido , Masculino , Valor Preditivo dos Testes , Melhoria de Qualidade , Medição de Risco , Índice de Gravidade de Doença , Fatores Sexuais , Ultrassonografia/métodos , Ultrassonografia/normas
9.
Nefrologia (Engl Ed) ; 41(4): 436-445, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-36165112

RESUMO

BACKGROUND AND OBJECTIVE: Cardiovascular disease (CVD) is the main cause of death in children with chronic kidney disease (CKD). Inflammation and endothelial dysfunction (ED) are found in the majority of these patients and are factors associated to CVD. Flow mediated dilatation (FMD) is a surrogate marker validated for evaluating ED. Our objective was to identify risk factors associated to ED in children with CKD. MATERIALS AND METHODS: Children 2-16 years of age were studied. Clinical information and biochemical variables were gathered, including intact parathyroid hormone (iPTH), interleukins 6 and 1b, high sensitivity C reactive protein (hsCRP), reduced glutathione, nitric oxide, malondialdehyde and homocysteine. FMD was measured, and considered altered if <7%. RESULTS: Included were 129 patients aged 13.1 ±â€¯2.6 years. FMD < 7% was found in 69 (52.7%). Patients with altered FMD had higher levels of triglycerides and hsCRP than those with normal FMD (145.5 mg/dl vs. 120.0 mg/dl, P = .042, y 1.24 U/L vs. 0.55 U/L, P = .007, respectively), as well as higher frequency of low iPTH (19.1% vs. 4.9%, P = .036). Levels of hsCRP correlated significantly with FMD (Rho = -0.28, P = .003). Patients with low iPTH (OR = 4.41, 95%CI 1.13-17.27, P = .033) and increased hsCRP (OR = 2.89, 95%CI 1.16-7.17, P = .022) had higher adjusted risk of having FMD < 7%. CONCLUSIONS: Hypertriglyceridemia, inflammation and low iPTH associated significantly with altered FMD. They are frequent, treatable risk factors for CVD.


Assuntos
Doenças Cardiovasculares , Insuficiência Renal Crônica , Adolescente , Biomarcadores , Proteína C-Reativa/análise , Doenças Cardiovasculares/etiologia , Criança , Pré-Escolar , Endotélio Vascular , Glutationa , Homocisteína , Humanos , Inflamação , Interleucinas , Malondialdeído , Óxido Nítrico , Hormônio Paratireóideo , Insuficiência Renal Crônica/complicações , Triglicerídeos
10.
Tob Prev Cessat ; 6: 55, 2020.
Artigo em Inglês | MEDLINE | ID: mdl-33083683

RESUMO

INTRODUCTION: We analyze the activities carried out by primary care (PC) physicians and nurses with respect to smoking cessation and evaluate their self-reported training, knowledge, and behavior. METHODS: A cross-sectional study was conducted including 1514 PC physicians and nurses from June 2016 to March 2017, in Spain. The main variable was Good Practice (GP) in attention to smokers. To identify associated factors, a multilevel logistic regression model was used adjusted for sex, age, type of center, contract, years of employment, tobacco consumption, and self-reported training/knowledge. RESULTS: Of the 792 physicians and 722 nurses, 48.6% referred to GP in smoking cessation management. The finding related to: being a non-smoker (OR=1.8; 95% CI: 1.2-2.5) or ex-smoker (OR=1.4; 95% CI: 1.02-2.1), having a good level of knowledge (OR=1.8; 95% CI: 1.3-2.4) and training (OR=2.4; 95% CI: 1.8-3.2), and, to a lesser extent, being female (OR=1.3; 95% CI: 1.03-1.7), and work experience >10 years (OR=1.4; 95% CI: 1.03-1.9). The main GP barriers were: lack of time (45.5%), organizational problems (48.4%), and 35.4% lack of training. CONCLUSIONS: The GP of PC physicians and nurses regarding smoking cessation management is related to being non-smokers or ex-smokers, and having sufficient training and knowledge. Lack of time and organizational problems were considered to be the main barriers. The promotion of training activities in the Spanish National Health Service with the support of scientific societies is required.

11.
J Immunol Res ; 2020: 5692829, 2020.
Artigo em Inglês | MEDLINE | ID: mdl-32676508

RESUMO

Interleukin- (IL-) 17 is increased in acute myocardial infarction (AMI) and plays a key role in inflammatory diseases through its involvement in the activation of leukocytes. Here, we describe for the first time the effect of IL-17 in the migration and activation of monocyte subsets in patients during ST-segment elevation myocardial infarction (STEMI) and post-STEMI. We analyzed the circulating levels of IL-17 in patient plasma. A gradual increase in IL-17 was found in STEMI and post-STEMI patients. Additionally, IL-17 had a powerful effect on the recruitment of CD14++CD16+/CD14+CD16++ monocytes derived from patients post-STEMI compared with the monocytes from patients with STEMI, suggesting that IL-17 recruits monocytes with inflammatory activity post-STEMI. Furthermore, IL-17 increased the expression of TLR4 on CD14 + CD16 - and CD14++CD16+/CD14+CD16++ monocytes post-STEMI and might enhance the response to danger-associated molecular patterns post-STEMI. Moreover, IL-17 induced secretion of IL-6 from CD14++CD16- and CD14++CD16+/CD14+CD16++ monocytes both in STEMI and in post-STEMI, which indicates that IL-17 has an effect on the secretion of proinflammatory cytokines from monocytes during STEMI and post-STEMI. Overall, we demonstrate that in STEMI and post-STEMI, IL-17 is increased and induces the migration and activation of monocyte subsets, possibly contributing to the inflammatory response through TLR4 and IL-6 secretion.


Assuntos
Endotélio Vascular/metabolismo , Interleucina-17/metabolismo , Monócitos/imunologia , Infarto do Miocárdio/imunologia , Adulto , Idoso , Idoso de 80 Anos ou mais , Eletrocardiografia , Endotélio Vascular/patologia , Feminino , Células Endoteliais da Veia Umbilical Humana , Humanos , Interleucina-6/metabolismo , Receptores de Lipopolissacarídeos/metabolismo , Masculino , Pessoa de Meia-Idade , Receptores de IgG/metabolismo , Receptor 4 Toll-Like/metabolismo
12.
Artif Cells Nanomed Biotechnol ; 48(1): 1022-1035, 2020 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-32663040

RESUMO

Here, temperature-sensitive hybrid poly(N-isopropylacrylamide) (pNIPAM) nanosystems with magnetic response are synthesised and investigated for controlled release of 5-fluorouracil (5FU) and oxaliplatin (OXA). Initially, magnetic nanoparticles (@Fe3O4) are synthesised by co-precipitation approach and functionalised with acrylic acid (AA), 3-butenoic acid (3BA) or allylamine (AL) as comonomers. The thermo-responsive polymer is grown by free radical polymerisation using N-isopropylacrylamide (NIPAM) as monomer, N,N'-methylenbisacrylamide (BIS) as cross-linker, and 2,2'-azobis(2-methylpropionamidene) (V50) as initiator. We evaluate particle morphology by transmission electron microscopy (TEM) and particle size and surface charge by dynamic light scattering (DLS) and Z-potential (ZP) measurements. These magnetically active pNIPAM@ nanoformulations are loaded with 5-fluorouracil (5FU) and oxaliplatin (OXA) to determine loading efficiency, drug content and release as well as the cytotoxicity against T-84 colon cancer cells. Our results show high biocompatibility of pNIPAM nanoformulations using human blood cells and cultured cells. Interestingly, the pNIPAM@Fe3O4-3BA + 5FU nanoformulation significantly reduces the growth of T-84 cells (57% relative inhibition of proliferation). Indeed, pNIPAM-co-AL@Fe3O4-AA nanosystems produce a slight migration of HCT15 cells in suspension in the presence of an external magnetic field. Therefore, the obtained hybrid nanoparticles can be applied as a promising biocompatible nanoplatform for the delivery of 5FU and OXA in the improvement of colon cancer treatments.


Assuntos
Resinas Acrílicas/química , Materiais Biocompatíveis/química , Portadores de Fármacos/química , Nanopartículas de Magnetita/química , Temperatura , Liberação Controlada de Fármacos , Fluoruracila/química , Concentração de Íons de Hidrogênio , Tamanho da Partícula
13.
Oxid Med Cell Longev ; 2020: 6286105, 2020.
Artigo em Inglês | MEDLINE | ID: mdl-32566091

RESUMO

There are different pathologies associated with amyloidogenic processes caused by the increase of reactive oxygen species (ROS) and the overactivation of inflammatory responses. These alterations are present in different regions of the anterior segment of the eye, and they have been associated with the development and progression of ocular pathologies, such as glaucoma, dry eye syndrome, keratitis, and cataracts among other pathologies. Aim. To discuss briefly the anatomical characteristics of the anterior segment of the eye and describe the interaction between oxidative stress (OS) and inflammatory responses, emphasizing the misfolding of several proteins leading to amyloidogenic processes occurring in the anterior segment and their implications in the development of ocular diseases. We performed a search on PubMed, CINAHL, and Embase using the MeSH terms "eye," "anterior segment", "inflammation", "oxidative stress", and "amyloidosis". The search encompassed manuscripts published up to April 2019. A hundred forty-four published studies met the inclusion criteria. We present the current knowledge regarding the interaction between OS and the activation of inflammatory processes and how both can cause conformational changes in several peptides and proteins in each compartment of the anterior segment. However, we found that there is no consensus about which factor is the first to cause amyloidosis. Our conclusions suggest that there is an interplay among these factors forming a vicious cycle that leads to the loss of protein structure in ocular pathologies, and multifactorial therapies should be developed to avoid protein misfolding and to stop the progression of ocular pathologies.


Assuntos
Amiloidose/complicações , Amiloidose/patologia , Segmento Anterior do Olho/patologia , Inflamação/complicações , Inflamação/patologia , Estresse Oxidativo , Animais , Humanos , Espécies Reativas de Oxigênio/metabolismo , Malha Trabecular/patologia
15.
Psicol. conoc. Soc ; 10(1): 252-281, 2020.
Artigo em Espanhol | LILACS-Express | LILACS | ID: biblio-1115114

RESUMO

Resumen: En este artículo se reflexiona sobre la instrumentación del Consentimiento Informado (CI) en investigaciones cualitativas a partir de experiencias de un colectivo de investigadoras de la Facultad de Psicología de la Universidad de la República (Uruguay). Se abordan aspectos históricos sobre el origen del CI contextualizado en los Comités de Ética, ubicando la situación de la Facultad de Psicología de la Universidad de la República. Luego, se profundiza en la ética y en el CI como procesos reflexivos y dialógicos, más allá de los aspectos formales establecidos institucionalmente, y sus particularidades en investigaciones cualitativas desde la Psicología Social Comunitaria. A partir de situaciones particulares, ligadas a investigaciones realizadas por integrantes del colectivo, se reflexiona sobre: a) el rol de las instituciones en la implementación del CI en personas con historias de institucionalización. b) el anonimato y la posibilidad de coautoría. La introducción del CI no es inocua, por ello se piensa en los sentidos que estos procedimientos portan, su incidencia en los vínculos que se establecen en el proceso investigativo y su relación con la ética en la investigación. Las conclusiones versan sobre la necesidad de promover institucionalmente mecanismos para la reflexión, evitando la burocratización de la ética en los procesos de investigación, así como la importancia de la flexibilización y creatividad en cuanto a formas de dar consentimiento en contextos comunitarios.


Abstract: This paper presents a reflection about the implementation of Informed Consent (IC) in qualitative research, based on the experiences of a women researchers group from Facultad de Psicología de la Universidad de la República (Uruguay). In a first instance, a brief historical description is performed, regarding the origins of Ethics Committees and IC in general and in Facultad de Psicología de la UdelaR in particular. Then, an ethics and Informed Consent instrumentation analysis is elaborated, as a reflexive and dialogic process beyond the formal aspects institutionally established, and it's particularities in qualitative research from a Community Social Psychology approach. Through the narration of particular situations related to research project developed by members of the group, we reflect on: a) the role of institutions during the implementation of IC in people with institutionalization process. b) anonymity and co-authorship possibilities. IC's implementation is not an innocuous process, thus the necessity of exploring the meanings that these procedures carry, their incidence on the relationships that are established within research process and its link with research ethics. In the concluding section, the need of institutional devices to promote mechanisms for reflexive vigilance is presented, in order to avoid the bureaucratization of ethics in research, as well as the importance of flexibility and creativity in community consent contexts.


Resumo: Neste artigo, refletimos sobre a implementação do Consentimento Livre e Esclarecido (TC) em pesquisa qualitativa com base nas experiências de um grupo de pesquisadores da Faculdade de Psicologia da Universidade da República (Uruguai). Aspectos históricos sobre a origem do CI contextualizado nos Comitês de Ética são abordados, situando a situação da Faculdade de Psicologia da Universidade da República. Em seguida, a ética e o CI são aprofundados como processos reflexivos e dialógicos, além dos aspectos formais estabelecidos institucionalmente, e suas peculiaridades na pesquisa qualitativa da Psicologia Social Comunitária. A partir de situações particulares, vinculadas a pesquisas realizadas por membros do coletivo, refletimos sobre: a) o papel das instituições na implementação do CI em pessoas com histórias de institucionalização. b) anonimato e possibilidade de coautoria. A introdução do QI não é inócua, pois pensamos sobre os significados que esses procedimentos carregam, sua incidência nos vínculos que se estabelecem no processo investigativo e sua relação com a ética na investigação. As conclusões são sobre a necessidade de promover institucionalmente mecanismos de reflexão, evitando a burocratização da ética nos processos de pesquisa, bem como a importância da flexibilidade e criatividade em termos de formas de dar consentimento em contextos comunitários.

16.
Pesqui. prát. psicossociais ; 14(3): 1-15, jul.-set. 2019.
Artigo em Espanhol | LILACS | ID: biblio-1040695

RESUMO

El artículo presenta los resultados del estudio "Ética en la Formación en Psicología Comunitaria" en Uruguay. Para la Psicología Comunitaria la dimensión ético-política es fundamental, por lo que su presencia en la formación profesional y académica es muy relevante. Se realizó un estudio descriptivo exploratorio, relevando y analizando los syllabus de cursos de Psicología Comunitaria y afines, en el Plan de Estudios 2013 de la Licenciatura de Psicología (Facultad de Psicología, Universidad de la República). Se abordaron las siguientes dimensiones: trabajo de campo, enfoque ético-político y metodología de enseñanza. Entre los resultados se destaca la presencia de la ética y de lo político en las guías de curso y el énfasis en la reflexión ética durante el desarrollo de prácticas curriculares. En la discusión se exponen las oportunidades, los riesgos y los desafíos involucrados en dichos resultados. Se concluye en la necesidad de atender esta dimensión en la formación, en el marco de las características que presenta la sociedad contemporánea y sus requerimientos para la Psicología Comunitaria.


The paper presents the results of the study "Ethics in the Professional Training in Community Psychology" in Uruguay. For Community Psychology the ethical-political dimension is fundamental and, therefore, its presence in professional and academical training is very relevant. A descriptive exploratory study was conducted, collecting and analyzing data from the syllabus of Community Psychology and related disciplines courses, in the 2013 Curriculum of the Bachelor's Degree in Psychology (Psychology School, Universidad de la República). The following dimensions were addressed: fieldwork, ethical-political approach and teaching methodology. Among the results, the presence of ethics and politics in courses guidelines and an emphasis in ethical reflection during curricular practices stand out. In the discussion, the opportunities, risks and challenges involved in said results are exposed. It is concluded the necessity of attending to this dimension in the professional training, within the framework of the characteristics that contemporary society presents and its requirements for Community Psychology.


O artigo apresenta os resultados do estudo "Ética na Formação em Psicologia Comunitária" no Uruguai. Para a Psicologia Comunitária, a dimensão ético-política é fundamental e, por isso, sua presença na formação profissional e acadêmica é muito relevante. Foi realizado um estudo descritivo exploratório, relevando e analisando os syllabus de disciplinas de Psicologia Comunitária e afins no Currículo 2013 do Bacharelado em Psicologia (Faculdade de Psicologia, Universidad de la República). Foram abordadas as dimensões a seguir: trabalho de campo, enfoque ético-político e metodologia de ensino. Entre os resultados se destaca a presença da ética e a política nas guias de disciplina e a ênfase na reflexão ética durante as práticas curriculares. Na discussão são expostos as oportunidades, os riscos e os desafios envolvidos nos referidos resultados. Conclui-se na necessidade de atender esta dimensão na formação, no contexto das características que apresenta a sociedade contemporânea e seus requerimentos para a Psicologia Comunitária.


Assuntos
Psicologia Social , Ética , Avaliação Educacional , Capacitação Profissional
17.
Molecules ; 24(9)2019 Apr 26.
Artigo em Inglês | MEDLINE | ID: mdl-31027319

RESUMO

This research focused on obtaining eicosapentaenoic acid (EPA, 20:5 n-3) and docosahexaenoic acid (DHA, 22:6 n-3) (EPA+DHA) concentrates from refined commercial salmon oil (RCSO). Independent variables of the complexation process were optimized by means of the application of response surface methodology (RSM) in order to obtain the maximum content of such fatty acids (FAs). As a result of employing the optimized conditions for all the variables (6.0, urea:FA content ratio; -18.0 °C, crystallization temperature; 14.80 h, crystallization time; 500 rpm, stirring speed), high contents of EPA and DHA could be obtained from RCSO, achieving increases of 4.1 and 7.9 times in the concentrate, with values of 31.20 and 49.31 g/100 g total FA, respectively. Furthermore, a 5.8-time increase was observed for the EPA + DHA content, which increased from 13.78 to 80.51 g/100 g total FA. It is concluded that RCSO can be transformed into a profitable source of EPA and DHA (EPA+DHA), thus leading to a product with higher commercial value.


Assuntos
Ácidos Docosa-Hexaenoicos/análise , Ácido Eicosapentaenoico/análise , Ácidos Graxos/química , Óleos de Peixe/análise , Óleos de Peixe/química , Ureia/química , Valor Nutritivo
18.
Nanomaterials (Basel) ; 9(4)2019 Apr 19.
Artigo em Inglês | MEDLINE | ID: mdl-31010180

RESUMO

Many therapeutically active molecules are non-soluble in aqueous systems, chemically and biologically fragile or present severe side effects. Lipid-based nanoparticle (LBNP) systems represent one of the most promising colloidal carriers for bioactive organic molecules. Their current application in oncology has revolutionized cancer treatment by improving the antitumor activity of several chemotherapeutic agents. LBNPs advantages include high temporal and thermal stability, high loading capacity, ease of preparation, low production costs, and large-scale industrial production since they can be prepared from natural sources. Moreover, the association of chemotherapeutic agents with lipid nanoparticles reduces active therapeutic dose and toxicity, decreases drug resistance and increases drug levels in tumor tissue by decreasing them in healthy tissue. LBNPs have been extensively assayed in in vitro cancer therapy but also in vivo, with promising results in some clinical trials. This review summarizes the types of LBNPs that have been developed in recent years and the main results when applied in cancer treatment, including essential assays in patients.

19.
Tob Prev Cessat ; 5: 9, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-32411874

RESUMO

INTRODUCTION: Our aim was to ascertain how the anti-smoking legislation of 2005/2010 has affected the behavior of primary healthcare center (PHC) personnel (medical and nonmedical) with respect to their attitudes towards tobacco, its consumption and the legislative changes. METHODS: We conducted a multi-center descriptive study of a randomized conglomerate sample of PHC personnel from each Autonomous Community in Spain. The questionnaire covered tobacco consumption, and knowledge/attitudes towards smoking and legislation. The statistical analysis used SPSS software. RESULTS: The sample consisted of 2040 PHC employees (1578 women, 77.4%). Never smokers, ex-smokers, and smokers represented 46.7%, 37.8%, and 15.5% of the sample, respectively. Tobacco prevalence amongst physicians and nurses was 12.3%. Following the introduction of the antismoking legislation, a decrease in consumption was observed. Most of the participants considered that tobacco consumption affected health, was an addictive illness, and passive smoking had an impact on the health of non-smokers. Whilst 91.6% agreed with the current legislation, only 25% felt that it encouraged cessation. CONCLUSIONS: Spanish primary healthcare professionals have a relatively low prevalence of smoking compared to the general population. It is necessary to implement more legislative measures to improve and maintain this outcome.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA